Dachaigh › Leukemia Lymphocytic Cronach › California › San Diego
Sgrùdaidhean clionaigeach Leukemia Lymphocytic Cronach ann an San Diego, CA
Tha 10 sgrùdaidhean airson Leukemia Lymphocytic Cronach a’ lorg phàirtichean aig làraichean ann agus timcheall air San Diego (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
A’ fastadhÌre 1/2
- University of California San Diego (Ucsd) Moores Cancer Center, La Jolla · 11 mìle air falbh
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
A’ fastadhÌre 3
- Kaiser Permanente-San Diego Zion, San Diego
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
A’ fastadhÌre 3
- Kaiser Permanente-San Diego Zion, San Diego
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
A’ fastadhÌre 1/2
- Research Site, La Jolla · 11 mìle air falbh
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
A’ fastadhÌre 3
- Scripps Prebys Cancer Center, San Diego
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
A’ fastadhÌre 3
- Scripps Prebys Cancer Center, San Diego
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
A’ fastadhÌre 3
- University of California San Diego (Ucsd) Moores Cancer Center, La Jolla · 11 mìle air falbh
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
A’ fastadhÌre 3
- Moores Cancer Center ( Site 0003), La Jolla · 11 mìle air falbh
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
A’ fastadhÌre 2
- Scripps Health, San Diego
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
A’ fastadhÌre 2
- Moores Cancer Center at UC San Diego /ID# 230157, La Jolla · 11 mìle air falbh
Sgrùdaidhean Leukemia Lymphocytic Cronach ann am bailtean eile
- Boston, MA31 sgrùdaidhean
- Columbus, OH28 sgrùdaidhean
- Durham, NC27 sgrùdaidhean
- Washington, DC22 sgrùdaidhean
- Seattle, WA20 sgrùdaidhean
- Rochester, MN18 sgrùdaidhean
- New York City, NY18 sgrùdaidhean
- Houston, TX17 sgrùdaidhean
- Baldwin Park, CA16 sgrùdaidhean
- Milwaukee, WI15 sgrùdaidhean
- Chicago, IL14 sgrùdaidhean
- Cincinnati, OH14 sgrùdaidhean
Sgrùdaidhean eile ann an San Diego
- Aillse Sgamhain Neo-chealla-beag48 sgrùdaidhean
- Aillse a' bhroilleach41 sgrùdaidhean
- Aillse (gach seòrsa)32 sgrùdaidhean
- Aillse Prostata31 sgrùdaidhean
- Ailse metastatach30 sgrùdaidhean
- Aillse colorectal25 sgrùdaidhean
- Cancer Ovarian24 sgrùdaidhean
- Cancer Pancreatic24 sgrùdaidhean
- Ailseachadh nan Sgamhan23 sgrùdaidhean
- Obesity23 sgrùdaidhean
- Fàilligeadh a' Chridhe23 sgrùdaidhean
- Depression21 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.